For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Record Date For Dividend: Multibagger Small Cap Pharma Stock Decides Date, 3-Months Return 71%

|

Gujarat Themis Biosyn Ltd is a small cap company that operates in Pharmaceuticals sector. The company has fixed record date for interim dividend. The stock has given multibagger returns in last 5 years and jumped 71% in just 3-months period only. The company has a market capitalisation of Rs 1254 crore. Check key takeaways below:

 

1. Gujarat Themis Biosyn Declares Record Date For Interim Dividend

1. Gujarat Themis Biosyn Declares Record Date For Interim Dividend

The board of directors of the company said in the BSE filing, "Declaration of an Interim Dividend for the Financial Year 2022-23 of Rs 4.40/- (Rupees Four and forty paise only) per equity share having face value of Rs 5/- i.e. 88% aggregating to Rs 6,39,26,289/- (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only). The Record date for the same is 2nd December, 2022."

Therefore, the company has decided the record date to be December 2, 2022.

2. Gujarat Themis Biosyn Stock Outlook
 

2. Gujarat Themis Biosyn Stock Outlook

The current market price of the stock is Rs 863 apiece with an intraday decline of 2.69%. The stock's 52-week high is Rs 915 apiece and 52-week low is Rs 317 apiece, respectively.

3. Gujarat Themis Biosyn Return

3. Gujarat Themis Biosyn Return

The stock has given multibagger returns over the years with 5-years return at 1882%, 3-years return at 1632%, and 3-months return 71%. The stock has surged 61% in last 1-year. In 1-month, it has jumped 22%.

4. Gujarat Themis Biosyn About

4. Gujarat Themis Biosyn About

It was incorporated in 1981 as a joint sector company with GIIC Ltd and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd.

It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007, according to its official website.

Disclaimer

Disclaimer

The stock provides details pertaining to record date for interim dividend. Greynium Information Technologies and the author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.

 

Story first published: Monday, November 21, 2022, 12:59 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X